国际医药卫生导报2010,Vol.16Issue(23) :2898-2900.DOI:10.3760/cma.j.issn.1007-1245.2010.23.026

硫酸氢氯吡格雷联合低分子肝素钙治疗进展性脑梗死疗效研究

Study on curative effect of clopidogrel bisulfate combined with low molecular weight heparin in the treatment of acute progressive cerebral infarction

罗森华 黄伟胜 丘锦龙
国际医药卫生导报2010,Vol.16Issue(23) :2898-2900.DOI:10.3760/cma.j.issn.1007-1245.2010.23.026

硫酸氢氯吡格雷联合低分子肝素钙治疗进展性脑梗死疗效研究

Study on curative effect of clopidogrel bisulfate combined with low molecular weight heparin in the treatment of acute progressive cerebral infarction

罗森华 1黄伟胜 1丘锦龙1
扫码查看

作者信息

  • 1. 514200,梅州市大埔县人民医院内一科
  • 折叠

摘要

目的 观察硫酸氢氯吡格雷联合低分子肝素钙治疗进展性脑梗死的疗效及副作用.方法 117例患者随机分为治疗组62例和对照组55例,治疗组第一天给予硫酸氢氯吡格雷300mg,首剂口服,第二天起75 mg qd × 13d,低分子肝素钙4000Iu ih q12 h×7 d;对照组予阿司匹林肠溶片;两组同时酌情予降压、调控血糖、血脂、脱水及改善脑细胞代谢药物.结果 治疗组显效率(80.6%)及总有效率(91.9%)与对照组比较差异有显著性(P<0.01).结论 两种药物联合治疗进展性脑梗死有协同作用且安全有效.

Abstract

Objective To explore the curative effects of clopidogrel bisulfate combined with low molecular weight heparin in the treatment of acute progressive cerebral infarction. Methods 117 patients with progressive cerebral infarction were randomly divided into two groups, There were 62 patients in the treatment group and 55 patients in the control group. In the treatment group, clopidogrel bisulfate 300mg was apphed initial dose, followed by 75mg qd×13d and the low molecular weight Heparin 4000IU, twice a day,subcutaneous injection,for 7d; the control group were treated with oral enteric-coated aspirin 100mg, once a day. All of them were controlled with blood glucose, blood pressure, blood fat, dehydration and improved brain cells metabolism etc. Results The curative effects were compared between two groups, the treatment group was much better than that in the control group(P< 0.01) Conclusion Clopidogrel bisulfate combined with low molecular weight heparin in the treatment of acute progressive cerebral infarction is effective and safe.

关键词

硫酸氢氯吡格雷/低分子肝素钙/进展性脑梗死

Key words

Clopidogrel bisulfate/Low molecular weight heparin/Progressive brain infarction

引用本文复制引用

出版年

2010
国际医药卫生导报
中华医学会,国际医药卫生导报社

国际医药卫生导报

影响因子:0.781
ISSN:1007-1245
被引量10
参考文献量4
段落导航相关论文